Every Form 4 that Allstate Corp (ALL) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ALL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALL filings page.
Allstate Corp executive Suren Gupta reported equity compensation activity involving company common stock. He acquired 14,638 shares on February 13, 2026 as a grant/award upon conversion of a 2023 performance stock award under The Allstate Corporation 2019 Equity Incentive Plan, at a stated price of $0.0000 per share.
On the same date, 6,485 shares were disposed of at $207.51 per share to satisfy tax withholding obligations related to that conversion, meaning this was not an open-market sale. After these transactions, Gupta held 108,799 shares directly, plus 1,335 shares held indirectly through a 401(k) plan and 7 shares held indirectly through VVG Holdings LLC.
Allstate Corp executive Mario Rizzo reported a mix of equity award activity and related tax withholding. On February 13, 2026, he acquired 19,588 shares of common stock at $0.0000 per share as a grant under The Allstate Corporation 2019 Equity Incentive Plan, following conversion of a 2023 performance stock award.
On the same date, 7,975 shares of common stock at $207.51 per share were disposed of to satisfy tax withholding obligations tied to that conversion, described as a tax-withholding disposition rather than an open-market sale. After these direct transactions, he held 80,427 shares of common stock directly.
Separately, he reported indirect ownership of 1,670 shares of common stock held by a 401(k) plan, indicating retirement-plan exposure in addition to his direct holdings.
Allstate Corporation’s Chief Financial Officer John E. Dugenske reported equity-award related transactions in company common stock. On February 13, 2026, he acquired 19,588 shares at a price of $0.0000 per share through the conversion of a 2023 performance stock award under The Allstate Corporation 2019 Equity Incentive Plan.
On the same date, 7,976 shares were disposed of at $207.5100 per share to satisfy tax withholding obligations tied to that award conversion, rather than an open-market sale. After these transactions, he directly held 44,608 common shares, with an additional 338 shares held indirectly through a 401(k) plan.
Allstate Corporation executive Christine M. DeBiase, EVP, CLO and General Counsel, reported equity compensation activity in company common stock. On February 13, 2026, she acquired 11,624 shares through the conversion of a 2023 performance stock award under The Allstate Corporation 2019 Equity Incentive Plan. On the same date, 5,554 shares were withheld to cover tax obligations related to this conversion, leaving her with 11,261.904 common shares held directly after these transactions.
ALLSTATE CORP executive Mark Q. Prindiville reported equity compensation activity involving company common stock. He acquired 7,233 shares at no cost through the conversion of a 2023 performance stock award under The Allstate Corporation 2019 Equity Incentive Plan. To cover related tax withholding obligations, 2,513 shares were disposed of at a price of $207.51 per share. After these transactions, he directly owned 26,994 common shares, a net increase of 4,720 shares.
Allstate Corp executive Elizabeth Brady reported equity compensation activity involving company common stock. She acquired 8,912 shares of common stock on February 13, 2026 at $0.00 per share through the conversion of a 2023 performance stock award under The Allstate Corporation 2019 Equity Incentive Plan.
On the same date, 3,256 shares were disposed of at a price of $207.51 per share to satisfy tax withholding obligations related to that award conversion. Following these transactions, she directly held 27,666 common shares and indirectly held 202 shares through a 401(k) plan.
The Allstate Corporation executive Christine M. DeBiase reported routine equity compensation activity in company stock. On February 3, 2026, previously awarded restricted stock units converted into 2,538 shares of Allstate common stock at $0 exercise price under the 2019 Equity Incentive Plan. To cover tax withholding, 1,071 shares of common stock were withheld or disposed of at a price of $201.77 per share. After these transactions, DeBiase directly owned 5,191.904 shares of Allstate common stock.
The Allstate Corporation Chairman, President and CEO Thomas J. Wilson reported multiple open-market sales of Allstate common stock on February 2, 2026. The transactions, coded as sales, covered blocks of 1,605, 1,572, 13,271 and 359 shares at weighted average prices between $198.7714 and $201.5107, with actual trade prices ranging from $198.23 to $201.655.
These sales were executed under a Rule 10b5-1 trading plan adopted on June 27, 2025. After the reported sales, Wilson directly owned 77,601.303 Allstate common shares and also had indirect beneficial holdings through several GRATs, a 401(k) plan, and a remainder trust.
Allstate Corporation director Monica J. Turner reported an equity award transaction. On 02/01/2026, 456 restricted stock units converted into 456 shares of Allstate common stock at a price of $0.00 per share under the 2017 Equity Compensation Plan for Non-Employee Directors.
Following the conversion, Turner directly owns 456 shares of Allstate common stock and no longer holds the 456 restricted stock units, reflecting a shift from derivative to outright share ownership rather than a market sale or purchase.
The Allstate Corporation’s Chairman, President & CEO Thomas J. Wilson reported multiple open-market sales of company common stock on January 12, 2026. Across several trades coded as sales, he sold a total of 16,807 shares at weighted average prices ranging from $205.6779 to $209.9939, with actual sale prices spanning from $205.30 to $210.42.
The filing notes that these transactions were carried out under a Rule 10b5-1 trading plan adopted on June 27, 2025, indicating they were pre-arranged. Following the reported sales, Wilson directly beneficially owns 94,408.303 shares of Allstate common stock. He also reports indirect holdings, including 31,900 shares held by a 2024-C GRAT and 69,822 shares held by a 2025-A GRAT, along with additional trust and plan positions.
Allstate Corporation executive Suren Gupta, President, Enterprise Solutions, reported an employee stock option exercise and related stock sale. On January 7, 2026, he exercised an employee stock option for 19,593 shares of Allstate common stock at an exercise price of $62.32 per share and acquired the underlying shares. On the same date, he reported selling 19,593 shares of Allstate common stock at a reported price of $210 per share.
After these transactions, Gupta directly owned 100,646 shares of Allstate common stock. He also had indirect holdings of 1,335 shares through a 401(k) plan and 7 shares through VVG Holdings LLC.
The Allstate Corporation’s Chairman, President and CEO Thomas J. Wilson reported multiple open-market sales of Allstate common stock on January 2, 2026. The Form 4 shows four sale transactions of common stock at weighted average prices of $204.0964, $204.8644, $206.1694, and $206.9005, with corresponding post-transaction direct beneficial ownership levels of 120,826.303, 113,590.303, 112,450.303, and 111,215.303 shares.
The filing states these sales were executed under a Rule 10b5-1 trading plan adopted on June 27, 2025. It also notes that Wilson’s holdings include additional indirect ownership through several GRATs, a 401(k) plan, and a GRAT remainder trust, reflecting substantial ongoing equity exposure to Allstate.
The Allstate Corporation director reports routine stock compensation. On 01/01/2026, director Jacques P. Perold acquired 204 shares of Allstate common stock at $208.15 per share. The shares were received under The Allstate Corporation 2017 Equity Compensation Plan for Non-Employee Directors as stock in lieu of cash compensation. After this transaction, he beneficially owned 204 Allstate shares directly and 35 shares indirectly through a trust.
Allstate Corporation director Margaret M. Keane reported a routine equity compensation transaction. On 01/01/2026, she acquired 162 shares of Allstate common stock at $208.15 per share through an election to receive stock instead of cash fees under Allstate’s 2017 Equity Compensation Plan for Non-Employee Directors. After this and prior activity, she beneficially owns 16,514.718 shares of Allstate common stock. This balance includes 76.041 shares accumulated between July 3, 2025 and January 2, 2026 through a dividend reinvestment program.
The Allstate Corporation director reports routine equity compensation activity. On 01/01/2026, the reporting person acquired 198 shares of Allstate common stock at $208.15 per share, electing to receive stock instead of cash fees under The Allstate Corporation 2017 Equity Compensation Plan for Non-Employee Directors. After this transaction, the director directly owned 5,653.379 Allstate common shares, which also include 48.254 shares accumulated through dividend reinvestment between July 3, 2025 and January 2, 2026.
The filing also shows 7,703.604 common share units held under The Allstate Corporation Amended and Restated Deferred Compensation Plan for Non-Employee Directors, representing deferred director fees and dividend equivalents. For the period from October 2, 2025 through January 2, 2026, the director received 37.612 additional common share units from dividends credited under this deferred compensation arrangement.
Allstate Corporation Chairman, President & CEO Thomas J. Wilson reported several internal transfers of Allstate common stock involving his personal trusts and direct ownership. On December 19, 2025, 61,308 shares previously held by the Thomas J. Wilson 2023-B GRAT Trust were distributed to his direct ownership, and 50,134 shares from the same 2023-B GRAT were transferred to the Thomas J. Wilson 2020 GRAT Remainder Trust at a reported price of $0 per share.
The filing also notes a distribution of 33,421 shares from the Thomas J. Wilson 2024-C GRAT Trust to direct ownership on the same date. After receiving these shares, he contributed a total of 94,729 shares to the Thomas J. Wilson 2025-E GRAT Trust. Following these moves, he continues to hold Allstate stock directly and indirectly through multiple GRATs and a 401(k) plan.
The Allstate Corporation’s chairman, president and CEO Thomas J. Wilson reported open-market sales of Allstate common stock and related option movements. On December 15, 2025, he sold Allstate shares in several transactions at weighted-average prices of $208.3456, $209.3955, $210.3659 and $210.9611 per share under a Rule 10b5-1 trading plan adopted on June 27, 2025.
After these sales, he directly owned 128,005.491 Allstate shares, with additional indirect holdings through multiple GRATs, a 401(k) plan and trusts. The filing also lists employee stock options with exercise prices of $122.64, $137.10 and $159.17 per share, some of which were transferred on December 12, 2025 to TJW Options LLC series entities, while other option tranches remain directly held and vest in increments through 2027.
The Allstate Corporation’s chairman, president and CEO Thomas J. Wilson reported open‑market sales of company stock. On 12/01/2025, he sold 12,603 shares of Allstate common stock at a weighted average price of $212.4797, with individual sale prices ranging from $212.040 to $213.025. The same day, he sold another 4,204 shares at a weighted average price of $213.2706, with trades between $213.060 and $213.530. These transactions were carried out under a Rule 10b5‑1 trading plan adopted on June 27, 2025. After these sales, Wilson directly holds 144,812.491 shares of Allstate common stock and also reports additional indirect ownership through several GRATs, a 401(k) plan, and a remainder trust.
The Allstate Corporation executive reports option exercises and share sales. President, Enterprise Solutions Suren Gupta exercised employee stock options to buy 750 shares of Allstate common stock at $62.32 per share on 11/26/2025 and 3,786 shares at the same exercise price on 11/28/2025. On each date, he sold the same number of shares in open-market transactions at weighted average prices of $215.0083 and $215.1334, respectively, under a Rule 10b5-1(c) trading plan adopted on June 9, 2025.
After these transactions, Gupta directly beneficially owns 100,646 Allstate shares, plus 1,329 shares through a 401(k) plan and 7 shares through VVG Holdings LLC. He also holds 19,593 remaining employee stock options with a $62.32 exercise price expiring on 02/11/2026.
The Allstate Corporation executive files Form 4 for option exercise and share sale. On 11/24/2025, the President, Enterprise Solutions of Allstate exercised employee stock options for 600 shares of common stock at an exercise price of $62.32 per share and then sold 600 shares of common stock in an open-market transaction at a weighted average price of $215.0175 per share. These trades were made under a pre-arranged Rule 10b5-1(c) trading plan adopted on June 9, 2025. Following the transactions, the reporting person beneficially owned 100,646 shares directly, 1,329 shares through a 401(k) plan, 7 shares through VVG Holdings LLC, and 24,129 employee stock options.
The Allstate Corporation (ALL) reported an insider equity transaction by its President, Enterprise Solutions, Suren Gupta. On 11/21/2025, he exercised an employee stock option for 21,871 shares of common stock at an exercise price of $62.32 per share and, on the same date, sold 21,871 shares of common stock in an open-market transaction at a weighted average price of $215.2125 per share.
The transactions were made under a pre-arranged Rule 10b5-1(c) trading plan adopted on June 9, 2025. After these transactions, he beneficially owned 100,646 shares of Allstate common stock directly, plus 1,329 shares through a 401(k) plan and 7 shares through VVG Holdings LLC, as reported in the filing.
The Allstate Corporation (ALL) reported that its Chairman, President & CEO, Thomas J. Wilson, sold Allstate common stock in open-market transactions on 11/17/2025. He sold 15,370 shares at a weighted average price of $213.1159, 1,137 shares at $213.9619, and 300 shares at $214.7028, with actual prices in disclosed ranges for each trade. These sales were made under a Rule 10b5-1 trading plan adopted on June 27, 2025, which is a pre-arranged plan for systematic stock sales. Following the reported transactions, Wilson beneficially owned 161,619.491 Allstate shares directly, in addition to multiple indirect holdings through various GRATs, a 401(k) plan, and a remainder trust.
The Allstate Corporation (ALL) reported an insider equity transaction by President, Enterprise Solutions, Suren Gupta. On 11/17/2025, Gupta exercised 400 employee stock options at an exercise price of $62.32 per share and then sold 400 shares of common stock in an open-market transaction at a weighted average price of $215.215 per share. These trades were made under a Rule 10b5-1(c) trading plan adopted on June 9, 2025. Following the transactions, Gupta beneficially owns 100,646 common shares directly, plus 1,329 shares through a 401(k) plan and 7 shares via VVG Holdings LLC, and holds 46,600 stock options for Allstate common stock.
Allstate Corporation (ALL) reported insider activity by President, Enterprise Solutions, Suren Gupta. On 11/14/2025 he exercised 1,400 stock options at $62.32 per share and sold 1,400 common shares at a weighted average price of $215.0221 per share under a pre-arranged Rule 10b5-1 trading plan adopted on June 9, 2025. On 11/17/2025, 385 shares were transferred as a gift at a price of $0. Following these transactions, he directly owns 100,646 Allstate shares, plus 1,329 shares through a 401(k) plan and 7 shares through VVG Holdings LLC.
The Allstate Corporation (ALL) reported insider activity: Chairman, President & CEO Thomas J. Wilson sold a total of 16,807 shares of common stock on 11/03/2025 through multiple open‑market transactions executed under a Rule 10b5‑1 trading plan adopted on June 27, 2025.
The weighted average sale prices were $188.7305 (5,930 shares), $189.3931 (7,791 shares), $190.4249 (2,101 shares), and $191.3729 (985 shares), with disclosed price ranges for each tranche. Following these sales, Wilson directly beneficially owns 178,426.491 shares.
Allstate Corporation (ALL) reported an insider equity transaction. On 11/03/2025, officer Zulfikar Jeevanjee converted 5,110 previously awarded restricted stock units into an equal number of common shares, without payment of consideration, under The Allstate Corporation 2019 Equity Incentive Plan.
On the same date, a separate transaction coded “F” shows the disposition of 2,251 common shares at $191.25 per share. Following these transactions, Jeevanjee directly beneficially owns 10,431 Allstate common shares.
Allstate (ALL) CEO Thomas J. Wilson reported open-market sales totaling 16,807 shares on 10/20/2025 pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2025. Tranches executed at weighted-average prices of $193.6903, $194.3583, $195.5023, and $196.5001.
After the transactions, he directly owns 195,233.491 Allstate shares. He also reports indirect beneficial holdings, including 111,442 shares by the 2023-B GRAT and 273,954 shares by the 2020 GRAT Remainder Trust.
Thomas J. Wilson, Chairman, President & CEO of The Allstate Corporation (ALL), reported open-market sales executed under a Rule 10b5-1 trading plan adopted on 06/27/2025. On 10/06/2025 he sold a total of 16,807 shares in three reported transactions with weighted average prices of $209.6272, $210.4799, and $211.1514; reported sale price ranges were $209.070–$211.280.
After these transactions the reporting person shows 212,040.491 shares held directly and several indirect holdings through trusts and plans totaling 785,718 shares (listed by vehicle). The Form 4 states the sales were effected pursuant to the trading plan and discloses dividend reinvestment activity adding 33.037 shares during April–October 2025.
Mario Rizzo, listed as Chief Operating Officer-AIC of The Allstate Corporation (ALL), reported changes in his beneficial ownership on 10/03/2025 via a Form 4. The filing shows 199 shares acquired upon conversion of a 2022 performance stock award and 89 shares withheld for tax obligations, leaving 68,814 shares reported as directly beneficially owned after the transactions. The report also discloses 1,662 shares held indirectly through a 401(k) plan. In derivative holdings, 224 employee stock options were reported as acquired with an exercise price of $210.82 and an expiration in 2035, and 57 restricted stock units (RSUs) were granted that convert in three equal increments on 10/03/2026, 10/03/2027, and 10/03/2028. The Form is signed by an attorney-in-fact on 10/07/2025.
Allstate Corporation (ALL) reporting person Jesse E. Merten completed equity transactions tied to long‑term awards and an option exercise in early October 2025. On 10/05/2025 538 shares were acquired on conversion of a 2022 performance stock award and 239 shares were withheld to cover tax obligations related to that conversion. Separately, an employee stock option with a $210.82 exercise price was exercised on 10/03/2025 producing 213 underlying shares, and 54 restricted stock units were granted on 10/03/2025 that vest in three equal increments through 10/03/2028. Following these actions, the reporting person beneficially owned 21,287 shares directly and 7,706 shares indirectly via a 401(k) plan.
Insider award of 7,115 restricted stock units at no cost, vesting in three equal annual installments. An executive officer, Zulfikar Jeevanjee (EVP & CTO - AIC), was granted 7,115 Restricted Stock Units (RSUs) on 10/03/2025 under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU converts to one share of Allstate common stock without payment on the conversion dates. The RSUs vest in three equal increments on 10/03/2026, 10/03/2027, and 10/03/2028. The reported grant shows 0 purchase price per unit and results in 7,115 shares beneficially owned following the award.
Allstate Corporation reported that its Chief Financial Officer, John E. Dugenske, received an award of 4,743 restricted stock units (RSUs) on 10/03/2025 under the 2019 Equity Incentive Plan. Each RSU converts to one share of common stock at no cost to the recipient and the award will vest in three equal installments on 10/03/2026, 10/03/2027, and 10/03/2028. Following the grant, Mr. Dugenske beneficially owns 4,743 shares tied to these RSUs. The Form 4 filing was signed by an attorney-in-fact on 10/07/2025.
Margaret M. Keane, a director of The Allstate Corporation (ALL), reported an acquisition of common stock on 10/01/2025. The Form 4 shows she received 160 shares at a price of $210.68 each as an election to take stock instead of cash compensation under the company’s 2017 Equity Compensation Plan for Non-Employee Directors. After the transaction the filing reports 16,276.677 shares beneficially owned (listed with a footnote marker). The Form 4 was signed by an attorney-in-fact on 10/03/2025. The filing identifies her relationship to the issuer as Director and indicates this was a one-person Form 4 filing.
Perry M. Traquina, a director of The Allstate Corporation (ALL), reported acquiring 195 shares of common stock on 10/01/2025 at a price of $210.68 per share by electing to receive stock instead of cash compensation under the company’s 2017 Equity Compensation Plan for Non-Employee Directors. After that transaction the reporting person directly beneficially owned 5,407.125 shares. Separately, the filing shows 7,665.992 common share units held under the Amended and Restated Deferred Compensation Plan for Non-Employee Directors, which represent deferred director fees and include dividend-equivalent units; 36.215 of those units were acquired as dividend equivalents for the period 7/03/2025 through 10/01/2025. The form is signed by an attorney-in-fact on behalf of the reporting person.
Richard T. Hume, a director of The Allstate Corporation (ALL), reported the conversion of 1,300 restricted stock units into 1,300 shares of common stock on 06/01/2025 under The Allstate Corporation 2017 Equity Compensation Plan for Non-Employee Directors. The conversion required no payment ($0) and increased his total beneficial ownership to 3,909 shares. The filing indicates the transaction code M and was signed on behalf of Mr. Hume by Meghan E. Jauhar as attorney-in-fact.